When purchasing a used pickup truck, it is crucial to make informed and constructive decisions based on the results of a ...

An FDA expert panel has reignited a decades-old debate over hormone therapy treatment for menopause, as advocates argue over black box warnings and and a controversial 20th-century study.

New Delhi: The Subject Expert Committee (SEC) under Central Drugs Standard Control Organisation's (CDSCO) Cardiovascular division has approved MSD Pharmaceuticals' proposal to expand prescribing ...

Earlier this year, in April, the apex court had already allowed a 90-day extension to the committee for its recommendations on the amendments proposed by the Fssai regarding Front-of-Pack Warning ...

Panel urges FDA to remove warnings on hormonal menopause therapy Experts convened by FDA head Martin Makary called on the agency to revise the drugs’ labeling, which has for years cautioned of cancer ...

Front-of-pack nutrition labelling is an evidence-based nutrition intervention that is recommended by the World Health Organization and other health agencies as an effective non-communicable disease ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and health care professionals.